LIM-Only Protein FHL2 Is a Positive Regulator of Liver X Receptors in Smooth Muscle Cells Involved in Lipid Homeostasis

Authors:

Abstract
The LIM-only protein FHL2 is expressed in smooth muscle cells (SMCs) and inhibits SMC-rich lesion formation. To further elucidate the role of FHL2 in SMCs we compared the transcriptome of SMCs derived from wild-type (WT) and FHL2-knockout (KO) mice. This revealed that in addition to previously recognized involvement of FHL2 in SMC proliferation, the cholesterol synthesis and Liver X Receptor (LXR) pathways are altered in the absence of FHL2. Using co-immunoprecipitation experiments we found that FHL2 interacts with the two LXR isoforms, LXRα and LXRβ. Furthermore, FHL2 strongly enhances transcriptional activity of LXR-element (LXRE)-containing-reporter constructs. ChIP experiments on the ABCG1 promoter revealed that FHL2 enhances the association of LXRβ with DNA. In line with these observations, we observed reduced basal transcriptional LXR activity in FHL2-KO SMCs compared to WT SMCs. This was also reflected in reduced expression of LXR target genes in intact aorta and aortic SMCs of FHL2-KO mice. Functionally, absence of FHL2 resulted in attenuated cholesterol efflux to both ApoA-1 and HDL in agreement with reduced LXR signalling. Collectively, our findings demonstrate that FHL2 is a transcriptional coactivator of LXRs and points towards FHL2 being an important determinant of cholesterol metabolism in SMCs.

This publication has 38 references indexed in Scilit: